First Time Loading...

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 316.9 USD -3.1% Market Closed
Updated: Jul 18, 2024
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
West Pharmaceutical Services Inc

Revenue
2.9B USD
Cost of Revenue
-1.8B USD
Gross Profit
1.1B USD
Operating Expenses
-426.5m USD
Operating Income
661.6m USD
Other Expenses
-92.9m USD
Net Income
568.7m USD

Margins Comparison
West Pharmaceutical Services Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
West Pharmaceutical Services Inc
NYSE:WST
23.6B USD
37%
23%
19%
US
Thermo Fisher Scientific Inc
NYSE:TMO
207.3B USD
40%
17%
14%
US
Danaher Corp
NYSE:DHR
181.9B USD
58%
22%
18%
KR
Samsung Biologics Co Ltd
KRX:207940
60.5T KRW
48%
29%
23%
CH
Lonza Group AG
SIX:LONN
38B CHF
36%
20%
10%
US
IQVIA Holdings Inc
NYSE:IQV
41.1B USD
35%
14%
9%
US
Agilent Technologies Inc
NYSE:A
38.8B USD
51%
20%
19%
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
59%
29%
21%
IE
ICON PLC
NASDAQ:ICLR
27.1B USD
30%
13%
8%
US
Illumina Inc
NASDAQ:ILMN
18.8B USD
61%
-1%
-29%
US
Waters Corp
NYSE:WAT
18.3B USD
60%
27%
21%
Country US
Market Cap 23.6B USD
Gross Margin
37%
Operating Margin
23%
Net Margin
19%
Country US
Market Cap 207.3B USD
Gross Margin
40%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 181.9B USD
Gross Margin
58%
Operating Margin
22%
Net Margin
18%
Country KR
Market Cap 60.5T KRW
Gross Margin
48%
Operating Margin
29%
Net Margin
23%
Country CH
Market Cap 38B CHF
Gross Margin
36%
Operating Margin
20%
Net Margin
10%
Country US
Market Cap 41.1B USD
Gross Margin
35%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 38.8B USD
Gross Margin
51%
Operating Margin
20%
Net Margin
19%
Country US
Market Cap 28.7B USD
Gross Margin
59%
Operating Margin
29%
Net Margin
21%
Country IE
Market Cap 27.1B USD
Gross Margin
30%
Operating Margin
13%
Net Margin
8%
Country US
Market Cap 18.8B USD
Gross Margin
61%
Operating Margin
-1%
Net Margin
-29%
Country US
Market Cap 18.3B USD
Gross Margin
60%
Operating Margin
27%
Net Margin
21%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
West Pharmaceutical Services Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
West Pharmaceutical Services Inc
NYSE:WST
23.6B USD
21%
16%
22%
20%
US
Thermo Fisher Scientific Inc
NYSE:TMO
207.3B USD
13%
6%
9%
8%
US
Danaher Corp
NYSE:DHR
181.9B USD
16%
10%
12%
10%
KR
Samsung Biologics Co Ltd
KRX:207940
60.5T KRW
9%
5%
9%
6%
CH
Lonza Group AG
SIX:LONN
38B CHF
7%
4%
9%
8%
US
IQVIA Holdings Inc
NYSE:IQV
41.1B USD
22%
5%
11%
9%
US
Agilent Technologies Inc
NYSE:A
38.8B USD
21%
11%
14%
14%
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
-849%
23%
48%
28%
IE
ICON PLC
NASDAQ:ICLR
27.1B USD
8%
4%
8%
6%
US
Illumina Inc
NASDAQ:ILMN
18.8B USD
-21%
-12%
-1%
-1%
US
Waters Corp
NYSE:WAT
18.3B USD
69%
15%
26%
20%
Country US
Market Cap 23.6B USD
ROE
21%
ROA
16%
ROCE
22%
ROIC
20%
Country US
Market Cap 207.3B USD
ROE
13%
ROA
6%
ROCE
9%
ROIC
8%
Country US
Market Cap 181.9B USD
ROE
16%
ROA
10%
ROCE
12%
ROIC
10%
Country KR
Market Cap 60.5T KRW
ROE
9%
ROA
5%
ROCE
9%
ROIC
6%
Country CH
Market Cap 38B CHF
ROE
7%
ROA
4%
ROCE
9%
ROIC
8%
Country US
Market Cap 41.1B USD
ROE
22%
ROA
5%
ROCE
11%
ROIC
9%
Country US
Market Cap 38.8B USD
ROE
21%
ROA
11%
ROCE
14%
ROIC
14%
Country US
Market Cap 28.7B USD
ROE
-849%
ROA
23%
ROCE
48%
ROIC
28%
Country IE
Market Cap 27.1B USD
ROE
8%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 18.8B USD
ROE
-21%
ROA
-12%
ROCE
-1%
ROIC
-1%
Country US
Market Cap 18.3B USD
ROE
69%
ROA
15%
ROCE
26%
ROIC
20%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More